Faculty

My lab focuses on developing targeted therapies that target beta cell mass and function in the pathogenesis of diabetes. Currently funded projects include 1) the role of the circadian clock in beta cell metabolic flexibility, 2) Interventions and mechanisms addressing the role of circadian clock disruptions in diabetes, atherovascular, and Alzheimer's' diseases 3) the role of Tead1 and the Hippo pathway in the transcriptional regulation of quiescence and proliferation of beta cells. We are also interested in how these pathways affect obesity, adipose biology, and cardiac biology.